Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inhibition of ATP synthase (Bedaquiline); Inhibition of the Cytochrome bc1:aa3 supercomplex (Telacebec); Disruption of membrane potential and pH gradient (Pyrazinamide/Pyrazinoic acid); Competition for electrons in the respiratory chain (Clofazimine); Dissipation of the proton motive force (Verapamil).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial membrane energetics and pH homeostasis system (Mtb Bioenergetics).